US 11,672,422 B2
Transcutaneous analyte sensor
Mark C. Brister, Encinitas, CA (US); Jack Pryor, Ladera Ranch, CA (US); John Nolting, Poway, CA (US); Jacob S. Leach, San Diego, CA (US); Luis Pestana, San Diego, CA (US); Nelson Quintana, San Diego, CA (US); Vance Swanson, San Diego, CA (US); Paul V. Goode, Jr., Round Rock, TX (US); and James Patrick Thrower, Oakland, NJ (US)
Assigned to Dexcom, Inc., San Diego, CA (US)
Filed by DexCom, Inc., San Diego, CA (US)
Filed on Oct. 24, 2018, as Appl. No. 16/169,673.
Application 16/169,673 is a continuation of application No. 15/586,134, filed on May 3, 2017, abandoned.
Application 15/586,134 is a continuation of application No. 14/576,103, filed on Dec. 18, 2014, granted, now 9,668,682, issued on Jun. 6, 2017.
Application 14/576,103 is a continuation of application No. 12/869,996, filed on Aug. 27, 2010, granted, now 9,451,910, issued on Sep. 27, 2016.
Application 12/869,996 is a continuation of application No. 11/855,101, filed on Sep. 13, 2007, abandoned.
Prior Publication US 2019/0059730 A1, Feb. 28, 2019
Int. Cl. A61B 5/145 (2006.01); A61B 5/1486 (2006.01); A61B 5/00 (2006.01); A61B 5/15 (2006.01); G16Z 99/00 (2019.01); A61B 5/1473 (2006.01)
CPC A61B 5/0022 (2013.01) [A61B 5/1411 (2013.01); A61B 5/1473 (2013.01); A61B 5/1486 (2013.01); A61B 5/14507 (2013.01); A61B 5/14532 (2013.01); A61B 5/14546 (2013.01); A61B 5/14865 (2013.01); A61B 5/150534 (2013.01); A61B 5/6832 (2013.01); A61B 5/6833 (2013.01); A61B 5/6848 (2013.01); A61B 5/6849 (2013.01); A61B 5/742 (2013.01); G16Z 99/00 (2019.02); A61B 5/0002 (2013.01); A61B 5/150022 (2013.01); A61B 2560/0214 (2013.01); A61B 2560/0223 (2013.01); A61B 2562/08 (2013.01); Y02A 90/10 (2018.01)] 15 Claims
OG exemplary drawing
 
1. A sensor system for measuring an analyte concentration in a host comprising:
a transcutaneous analyte sensor configured for insertion into the host's tissue, wherein the transcutaneous analyte sensor comprises an in vivo portion and an ex vivo portion, wherein the transcutaneous analyte sensor is configured to measure the analyte concentration in the host;
a housing configured to be disposed outside of the host's tissue, wherein the housing comprises a plurality of layers and is configured to at least partially house:
the ex vivo portion of the transcutaneous analyte sensor;
a flexible circuit board disposed in a first layer of the plurality of layers;
a processor configured to process sensor data, wherein the sensor data is associated with the analyte concentration, wherein the processor is coupled to the flexible circuit board; and
a flexible battery configured to provide power to at least one of the transcutaneous analyte sensor or the processor, wherein the flexible battery is coupled to the flexible circuit board, wherein the flexible battery is disposed in a second layer of the plurality of layers, wherein the second layer is disposed adjacent to a third layer of the plurality of layers, and wherein the third layer is an adhesive layer.